A company with a nasal spray formulation to treat osteoporosis is raising $2.4 million as it seeks to move its treatment through clinical trials, according to a Form D filing with the U.S. Securities and Exchange Commission. Azelon Pharmaceuticals’ teriparatide nasal spray had undergone initial human safety and pharmacology studies as of October. The latest […]
Azelon Pharmaceuticals in West Conshohocken, Pennsylvania, has received $4.5 million in Series A financing from three venture capital firms to develop its nasal spray formulation of teriparatide for the treatment of osteoporosis. Palo Alto, California-based Prospect Venture Partners, Lighthouse Capital Partners in Menlo Park, California, and Covington Venture Fund in Toronto were the sources of […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.